Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01898767 · ClinicalTrials.gov registry record
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 44
- Enrollment target
NCT01898767 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 44 participants.
The verdict
NCT01898767 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The long-range goal of this protocol is to more completely understand the risks and the pathophysiology of asthma exacerbations, in order to develop prevention strategies and/or expedite a return to complete control of baseline asthma symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-12-17 |
| Est. Completion | 2017-08-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01898767
The ClinicalTrials.gov registry entry for NCT01898767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01898767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01898767 about?
NCT01898767 is a clinical study titled "Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses". The long-range goal of this protocol is to more completely understand the risks and the pathophysiology of asthma exacerbations, in order to develop prevention strategies and/or expedite a return to complete control of baseline asthma symptoms.
What is the current status of trial NCT01898767?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2013-12-17. Estimated completion is 2017-08-29.
Who is sponsoring clinical trial NCT01898767?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.